× Author Guidelines Publishing Ethics Join As Reviewer Advertise Current Issue Archive Submit Article Abstracting And Indexing Editorial Board Contact Editor-in-Chief Scope of the Journal About the Journal

JAPER is indexed in SCOPUS


Background: Celiac disease (CD) is an immune bowel defect  in individuals have a genetic susceptible to gluten diets. CD may co-occur in individuals that may be suffer from other immune extra-bowel disturbance such as autoimmune-mediated endocrine disorders, like primary Addison’s disease (AD)  in which described by decrease the production or activity  of adrenal gland hormones. The explanation of the association between these disorders propose that the steroid of adrenal gland , had convincing the onset of CD at the first time, and posteriorly hidden CD appearance .When AD onset and the serum steroid level reduced , the  CD disease was appeared  in full.   Where is an immunogenetic background is one elucidation for the linkage between the two disorders in which the two heterodimers DQ8 and DQ2 that susceptible to CD, were cis-encoded and were respectively association imbalance with haplotype of ADD individuals (DRB1*04 and DRB1*03)‎.

Keywords:  Celiac disease, Addison's disease, Gluten-free diet, Steroid, HLA DQ2


Addison's disease

Primary adrenal insufficiency (PAI) or (AD), is a scarce, possibility death and   can treat  . The large number status of autoimmune demolition of adrenal cortex give rise to (AD)[1-3]. (PAI) is a earnest pathologic disorder described by reduce output or activity of mineralocorticoids and adrenal androgen and/or glucocorticoids [4]. In spite of the fact that hypotension  and hyperpigmentation are the most particular marker, bowel manifestations are popular and can be the first disorder of the individuals[5,6].This disease may be grouped as primary, secondary or tertiary, producing from infirmities influencing the  cortex of adrenal gland[4]. In individuals at the beginning of their age, the disorder is widespread evenly in men  and women [2]. PAI individuals are at higher risk of promote another autoimmune disorders. PAI detection is predominatingly go slow by several months. Because the disease is scarce, unto specialized doctors in the curative region scarcely supervise a small number of individuals. Presently, the proceedings for diagnosis, remediation and continuation of this uncommon disorder change considerably within Europe. The existence of 21-hydroxylase ((P450c21) auto-antibodies  is the diagnosis of the popular autoimmune style of PAI [1,2,7] and distinguish of 21-hydroxylase in the zona glomerulosa  of adrenal cortex, is a essential autoantigen in unknown reason of AD[8]. A study addressed the immunological and clinical lineaments of AAD by a cross-sectional, inhabitance -based research that involve 660 individuals with ADD from the Swedish Addison Registry  from 2008 to 2014  and the cardiovascular risk factors was  analyzed, 3594 peoples from the inhabitance -based study in Northern Sweden, MONICA (monitoring of trends and determinants of cardiovascular disease),render as healthy people. Precise surveillance of AAD individuals is guaranteed to disclose linked autoimmune disorders show that   AAD individuals in Sweden did not have an elevated spread of hyperlipidemia , type 2 diabetes mellitus(DM), overweight  or hypertension. The raised glucocorticoid commutation potions could be a risk factor for hypertension[9]. Another study addressed the heritability of AAD and detect  the comorbidity  of disease-related autoimmune through twins in Sweden. An inhabitance -based longitudinal cohort of 112,100 Swedish twins was employed to compute the heritability of AAD, and to reconnoiter co- appearance of autoimmune disturbance in  ten organs of twin pairs with AAD. They specified 29 ADD twins. Of nine, five (5/9) was monozygotic and dizygotic  was pairs zero out of fifteen (0/15) dizygotic couple were suitable for AAD. In monozygotic twin pairs autoimmune disorders styles influenced by AAD demonstrate a large grade of resemblance than dizygotic twins. AAD heritability was very elevated. Monozygotic twin harmony for redoubled autoimmune appearances propose robust genetic effect on disorder  particulary in organ-specific [10].

AD is linked with the haplotypes DR4 (0404)-DQ8 and DR3-DQ2, especially high risk for disorder evolution is noticed when these appear in a heterozygous collection (DR4-DQ8/ DR3-DQ2) [2].

Celiac disease

(CD) is an autoimmune disturbance of small intestine [11-14]that evolves against grains gluten in genetically susceptible individuals[12-15] distinguished by exessive sensitivity to dietary gluten[16].Gluten protein  is showed in particular grains, and occasions an autoimmune response in CD individuals [17] .CD acts on individuals of any sex  or age[18]. The spread of CD worldwide is  about 1% [19,20]. The essential  remediation of(CD)  is gluten-free diet (GFD)in which eliminate the gluten protein  that gathering in grains for instance barley, triticale, rye and wheat [21-24] .The prolamin peptides in these grains give rise to painful ,chronic obliteration of microvilli of the epithelium of small bowel [25] and also can cause  osteoporosis, abdominal distension ,chronic diarrhea, anemia, weight-loss due to malabsorption of nutrients if it left without treatment [25-27]and osteopenia in which decrease using up of milk and dairy products may have an important role in limitation low bone mass in CD individuals, in spite of   no significant difference in exhaustion of milk between CD individuals and  healthy people[28]. The best methods of the diagnosis of individuals with CD are the traditional diarrhea in prevailing and silent CD style. Those with silent CD  have a reduction diarrhea, even though they have a normal symptoms  of CD that involve anemia ,an irritable bowel syndrome, osteoporosis, malignancy or neurologic diseases[29]. In patients with a genetic susceptibility for the disease,  the homozygous HLA DR3-DQ2[19,30,31], and /or HLA-DQ8[29,30] are together genotypes sensitive or important in evolution of CD disorder. [16,30-36]

Sensitivity to CD is robustly linked with special HLA class II alleles. And the evolution of CD  is also linked with non HLA genetic agents. [37,38]

Celiac disease and Addison’s disease

Multiple autoimmune syndrome (MAS) are the three  or more autoimmune disorders  clarify in a single individual [39]. A large number of CD individuals at risk for MAS[40]in which  the occurrence of CD in MAS individuals is increased  from 10- to 30-fold although in a large volume of CD individuals  occurrence are mute or clinically without symptomatic  . CD-related autoimmune disturbances can be either particular to organ, for instance Hashimoto’s thyroiditis and Type 1 diabetes mellitus (DM), or the autoimmune disturbances non  particular to organ for instance scleroderma, Sjogren’s syndrome ,systemic lupus erythematosus and rheumatoid arthritis [41] . CD repeatedly associated with a types of (MAS)  which are extra-digestive appearance, and   a systemic disorder rather than a disorder restricted to the bowel system and this made it returns to the category of autoimmune diseases[42].

A study show that one or several autoimmune disorders had evolved in 178 individuals, from 924 CD individuals retroactively recorded from 27 French adult gastroenterology and pediatric centers[40].

The researchers in a multicenter national study  inspect the connection between the spread of autoimmune diseases in CD individuals and the duration of  gluten consumption .For the early time the reports demonstrates that the increase the number of patients with autoimmune disorders in CD links to the duration of gluten consumption[43]. And other study showed that a GFD is important to prevent CD problems such as infertility ,anemia,  and osteoporosis, may also be useful in prevent and remediation of the underlying endocrinological disorders [44,45]. The connection between CD and many autoimmune defects  has been elucidated dividing of a public genetic agent[43]. Another study done on individuals with multiple endocrine defects, hypophysitis or alopecia, AD, associated with CD that are susceptible to autoimmune defects and analogous heredity are deem to be clarifications for these linkages [44]. Another study  found  that the raised spread of autoimmune disturbance is also high in first-grade relatives of CD individuals. The researchers announce  that autoimmune disorders elevated six-times through relatives and a risk elevated  increase with age. Mute CD was recognized in a parts of these relatives and the spread of autoimmune defect  in these parts as contrast to first-grade relatives not influenced by CD was significantly elevated about 6.3 ratio and the study confirm that the CD individuals in first- grade relatives have an elevated risk of autoimmune disorders, probably regarding to undiagnosed and, consequently, untreated CD[46].

CD and primary AD may coexist specially in individuals with autoimmune polyglandular syndrome(APS),  which are a scarce diseases that  combination of two  or more autoimmune endocrinological defect, involving type 1 DM , AD ,thyroiditis, primary gonadal failure  or hypoparathyroidism, take place[42].

The (APS) with AD are categorized into two various subtypes, on various methods of inheritance and on the basis of characteristic styles of disease combination. Individuals with autoimmune Addison's disease (AAD) are at comparatively high risk for other endocrine defect or non-endocrine autoimmune disorders[47].

The hesitation DR4-DQ8  and DR3-DQ2 haplotypes had no significant differences in a neoteric article in a greatest cohorts widespread of individuals with isolated AD contrast to individuals with APS II[48].

In (APS) type 1 ,there was about 12.5%  of CD cases, and in type 2 CD occur  in four out of 60 (6.7%) cases [49].

Lately, CD has been found in approximately 10% of individuals with (AAD)[4] and CD showed in one out of 40 (1\40) approximately (2.5%) of the isolated AAD patients[47].

The cohabitation of CD  and autoimmune endocrine disorder , has newly been described. A case of 23-year-old female have a (AAD), kariotypically normal automatic premature ovarian failure and hypothyroidism resulting from Hashimoto's thyroiditis. They investigate the serum  IgA anti-endomysium antibodies (EmA) level. In the biopsy of jejunal ,the existence of total villous atrophy and the favorable of Em A let the recognize of CD. These individuals with a (GFD) show a remarkable clinical development through a gradual reduction of the requirement of adrenal and thyroid replacements treatments, in three month duration .The EMA level in serum turn into negative after six months and a total mucosal healing in new  biopsy of jejunal found after twelve months. This condition confirmed the linkage  between CD and (APS);  the premature  diagnosis of these conditions is  important for the risk of disorder such as lymphoma if CD untreated and because CD give rise to the washout of replace hormonal remedy in autoimmune thyroid disorder individuals.[50]

Another study  on CD patients showed an extremely risk of AD occurance . Thus ,they advice to screened for CD in patients with AD. [51].Of 41 individuals with AD screened, five (12.2%) had CD: The three were formerly recognize CD ,involving testing their biopsies, the two had positive IgA‐(EMA) with a histological testing of biopsy gained in both cases without laboratory or clinical proof of malabsorption[52].

The risk for (PAI) is an amazing 11-times higher in CD individuals against non CD individuals, nevertheless the optimum risk is [53] ,in a research found that a twelve-year-old CD adolescent existing as acute adrenal insufficiency. A (GFD) had a curative function, where the large number of the symptoms and clinical marker of AD vanish in a small number of days [12].

While another study clarify that the GFD does not the change natural history of AAD by a study on  seven patients were explained as having formerly specified AAD and CD at the onset of the article. Out of seven ,six individuals had CD and were take GFD before AAD. [51] .

Chronic adrenal insufficiency is tricky to recognize. Typical problems involve generalized weakness ,chronic malaise and fatigue. Gastrointestinal appearance are existing in approximately fifty percent, which involve nausea ,lower abdominal cramps, anorexia and weight loss  [6] amenorrhoea ,anaemia ,reduced bone mineral density, pigmentation [52].

Another study found  that during  treatment of three patients ,two individuals with dermatitis herpetiformis and AD and  one with CD unaccompanied by the rash, but with AD  and juvenile DM. The susceptible factors to the multiple endocrine conditions in these individuals with small bowel disorder and/or gluten-sensitive skin stayed unknown. Of three two individuals had HLA-B8, nobody was recognized to have influenced on  relatives, and the AD noticed before, at the same time, or after the individuals contracted CD or dermatitis herpetiformis [54].

They recently suppose that  there is an association between CD individuals especially with serum IgA low level and AD disease.[55]

In individuals with AAD there is a large spread of both IgA deficiency and CD. So, the testing of tissue transglutaminase autoantibodies(tTGAbs) of the IgA  circulating levels and for IgA class   and screening for CD is serious. Individuals with (AAD) are susceptible to evolve other autoimmune aspects . A raise spread of CD with AAD has newly been appeared in individuals of North Europe. Lack of IgA is the greatest repeatedly kind of immunodeficiency through people and is existing in approximately one in each six hundred  persons in the people. IgA lack is popular in autoimmune disorder individuals, but information regarding  to AAD are yet not present  [49].

Immunogenetic background for the link between addison’s and celiac disease:

AAD individuals commonly take corticosteroid remedy to right their  reduction in adrenocortical. A study found that IgA-tTGAbs plus AAD individuals with a naturalistic infiltration of mucosa, the used of a large steroid surrogate remedy could decrease the  infilteration of mucosa, so this lead to  a incorrect negative estimate of biopsy of duodenal[49].

Another study describes CD in individuals ceasing chronic steroid treatment [56,57] and steroids have a well‐identification curative  function in the administration of refractory CD [58]. The technicalities by which steroids conserve the bowel mucosa contra injurious gluten influences are not obvious. In individuals with untreated and  not identified  CD, the steroids pharmacokinetics can be changed; particulary, those  with decreased the binding of protein and raise magnitude of apportionment hypoalbuminaemia. Hypoalbuminaemia modification may require  decreasing of steroids preservation potion [58].

A researchers found the reactivation of CD  in individuals after the remediation of Cushing’s disorder and occurrence of other defects specially autoimmune pathogenesis that characteristically have appear after a short time of surgical intrusion for Cushiug’s disease. They have noticed failure of ovary, an autoimmune painless thyroiditis, a Lofren syndrome. They believe  that high levels of steroid in the blood conserve against autoimmune diseases [57].

The HLA alleles are found in approximately 30-40% of  normal  individuals so its existence is important but not crucial [59]. The HLA typing is deemed by the new ESPGHAN guidelines a recognize device in CD. Class II HLA gives a lot of  datum related to autoimmune pathology [60], which are in charge of  about 40-50% of cases of Diabetes Mellitus(DM) [61]. There are susceptible to HLA sites in autoimmune disorders like HLA-DR B1 03 that keep safe against disorders (AD, DM). HLA-DR B1 07 were found in AD and DM. In addition to HLA DQ8, HLA DQ2  risk about  (90% of CD cases). Absence of  HLA DQ2/DQ8 in CD individuals are scarce, act for approximately 5% of those recognized with CD [59,62].

Other articles found that the heterodimer (HLA)-DQ2 (A1*0501, B1*0201) found in approximately 90- 95% of CD persons [63-68],in addition to another style DQA1*03 and DQB1*0302 (DQ8)[63,64,69]. The hesitancy of the DQA1*0501 and DQB1*02 alleles in CD Turkish children was elevated comparatively to healthy children. The DQA1B1 (*0501; *0201) haplotype was existing in 46 from 55  CD individuals approximately 83.6% and in12 from 50 healthy children approximately 24%. The residual 9 CD children were carried the haplotype DQ8 (A1*03;*B10302) [70].

The inherited predisposing to (AAD) is robustly linked with HLA (DR4-DQ8) (DRB1*04, DQA1*03 and DQB1*0302) haplotype and\or DR3- DQ2 (DRB1*03, DQA1*0501 and DQB1*02) haplotype [2] where is another study found that the HLA DQA1*0501 genotype is significantly more popular in AD person about 70% than  the healthy people about 43%[71].

Where is an analogous immunogenetic background is one clarification for the association between CD and AD disorders recognized by Betterle, et al in their individuals, the heterodimers susceptible to CD, DQ8 and DQ2, were cis-encoded and were in relationship to imbalance with DRB1*04 and DRB1*03. The haplotypes concerned with CD therefore involve the haplotypes susceptible to AAD[49].


Precocious recognition of CD disorder in greatly predisposed individuals may lead to the CD remediation  and evolved hegemony of related disorders.


I would like to thank some of lecturers in department of biology, college of sciences, Mosul University, for their advice in completing this research.


  1. Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C,Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, K¨ampe O,Løv° as K, Meyer G, Pearce SH. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med. 2014;275(2):104–115.
  2. Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø BG, Fougner KJ, Trovik T, Sørheim JI, Husebye ES. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J Clin Endocrinol Metab. 2002 Feb;87(2):618-23.
  3. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002 Jun;23(3):327-64.
  4. Nicolas C Nicolaides, M.D., George P Chrousos, MD, MACE, MACP, FRCP, and Evangelia Charmandari, M.D. Endotext Adrenal Insufficiency. Last Update: October 14, 2017.
  5. Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR. Prevalence of coeliac disease in Italian patients affected by Addison's disease. Scand J Gastroenterol. 2006;41(3):302-
  6. Tobin MV, Aldridge SA, Morris AI, Belchetz PE, Gilmore IT. Gastrointestinal manifestations of Addison's disease. Am J Gastroenterol. 1989 Oct;84(10):1302-5.
  7. Degros V, Pons L, Ghulam A, Racadot A.[21-hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies]. Ann Biol Clin (Paris). 1999;57(6):705-9.
  8. Winqvist O, Karlsson FA, K¨ampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison’s disease. Lancet. 1992; 339(8809):1559–1562
  9. Dalin F, Nordling Eriksson G, Dahlqvist P, Hallgren Å, Wahlberg J, Ekwall O and et al. Clinical and Immunological Characteristics of Autoimmune Addison Disease: A Nationwide Swedish Multicenter Study. J Clin Endocrinol Metab. 2017 Feb 1;102(2):379-38 doi: 10.1210/jc.2016-2522.
  10. Skov J, Höijer J, Magnusson PKE, Ludvigsson JF, Kämpe O, Bensing S. Heritability of Addison's disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins. Endocrine. 2017 Dec;58(3):521-527. doi: 1007/s12020-017-1441-z. Epub 2017 Oct 16.
  11. Miconi F,  Savarese E,  Miconi G, Cabiati G, Rapaccini V,  Principi N et al . Unusual onset of   Celiac Disease and Addison’s Disease in a 12-Year-Old   Boy. Int. J.     Environ. Res. Public Health 2017, 14, 855; doi:10.3390    /ijerph 14080855      
  12. Parzanese, I.; Qehajaj, D.; Patrinicola, F.; Aralica, M.; Chiriva-Internati, M.; Stifter, S.; Elli, L.; Grizzi, F. Celiac disease: From pathophysiology to treatment.
  13. Aggarwal M, Kashyap R and Aggarwal G .Celiac Disease with Acute Myeloid Leukemia: A Rare Association.. Pediat Therapeut 2013, 3:4DOI: 10.4172/2161-0665.1000163
  14. Chander A M, Yadav H, Jain S, Bhadada1SK, and Dhawan DK, Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity November 2018 | Volume 9 | Article 2597. doi: 10.3389/fmicb.2018.02597
  15. Sollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol 2005; 17:595–600.
  16. Khater D. Endocrinopathies in celiac disease: when the endocrinologist sees what is invisible to the gastroenterologist. Acta Biomed. 2018; 89(1): 117–121. doi: 10.23750/abm.v89i1.7119
  17. Ciaccio E J, Bhagat G, Lewis SK, Green Hp. Trends in gluten research and its relationship to autoimmune and allergic diseases . Informatics in Medicine Unlocked. 2016, 3: 7-14.
  18. Ludvigsson JF, Murray JA. Epidemiology of Celiac Disease. Gastroenterol Clin North Am. 2019 Mar;48(1):1- doi: 10.1016/j.gtc.2018.09.004. Epub 2018 Dec 13.
  19. Salazar C, García-Cárdenas JM and Paz-y-Miño C. Understanding Celiac Disease From Genetics to the Future Diagnostic Strategies. Clinical Medicine Insights: Gastroenterology 2017;10: 1–13 .DOI: 10.1177/1179552217712249.
  20. Welander A . Celiac disease:complications and the role of infection in pathogenesis.Stockholm 2012. From the department of medical clinical epidemiology. Unit Karolinska Institutet, Stockholm, Sweden
  21. Francavilla R, Cristofori F, Stella M, Borrelli G, Naspi G, Castellaneta S. Treatment of celiac disease: from gluten-free diet to novel therapies. Minerva Pediatr. 2014 Oct;66(5):501-16.
  22. Holtmeier W and  Caspary WF. Celiac disease .Orphanet Journal of Rare Diseases 2006;1(3): 1-8.
  23. Fasano A and Cattassi C. Current Approaches to Diagnosis and Treatment of Celiac Disease: An Evolving Spectrum Gastroenterology 2001;120:636–651
  24. Malamut G , Cording S, Cerf-Bensussan N. Recent advances in celiac disease and refractory celiac disease. F1000Research 2019; 8: (F1000 Faculty Rev):969 Last updated: 26 JUN 2019 .
  25. Osorio C& Wen  N& Gemini R& Zemetra R& D. von Wettstein  D& S. Rustgi S. Funct Integr Genomics. Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics. 2012 ;12(3):417-38. doi: 10.1007/s10142-012-0287-y. Epub 2012 Jun 26.
  26. Freeman HJ. Endocrine manifestations in celiac disease. World J Gastroenterol. 2016 Oct 14;22(38):8472-8479.
  27. Janaína Luz Narciso-Schiavon and Leonardo Lucca Schiavon .To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol. 2017; 23(5): 776–791. doi: 10.3748/wjg.v23.i5.776.
  28. Zingone F, Iovino P, Bucci C, Ciacci C. Coeliac  disease: no difference in milk and dairy products consumption in comparison with controls. bmjnph 2019;0:1–4. doi:10.1136/bmjnph-2018-000022.
  29. Peter H.R. Green. The many faces of celiac disease: Clinical presentation of celiac disease in the adult population. Gastroenterology. April 2005; 128(4), 74-78. DOI: https ://doi.org/ 10.1053 /j.gastro. 2005.02.016.
  30. Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, et al; TEDDY Study Group. Risk of pediatric celiac disease according to HLA haplotype and country .N Engl J Med 2014; 371 : 42-9.
  31. Piccini B, Vascotto M, Serracca L, Luddi A, Margollicci MA, Balestri P, Vindigni C, Bassotti G, Villanacci V. HLA-DQ typing in the diagnostic algorithm of celiac disease. Rev Esp Enferm Dig. 2012;104(5):248-54
  32. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, Ciclitira PJ, Sollid LM, Partanen J; European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64(4):469-77.
  33. Jennifer May-Ling Tjon & Jeroen van Bergen & Frits Koning. Celiac disease: how complicated can it get?.Immunogenetics (2010) 62:641–651.DOI 10.1007/s00251-010-0465-9
  34. Caio G , Volta U, Sapone A, Leffler D.A, De Giorgio R, Catassi C, and  Fasano A. Celiac disease: a comprehensive current review .BMC Medicine (2019) 17:142.  https://doi.org/10.1186/s12916-019-1380-z
  35. Luud J. W. J. Gilissen 1 , Ingrid M. van der Meer 1 and Marinus J. M. Smulders . Why Oats Are Safe and Healthy for Celiac Disease Patients. Med. Sci. 2016;4(4). pii: E21. doi: 10.3390/medsci4040021.
  36. Brown NK, Guandalini S, Semrad C, Kupfer SS.A Clinician’s Guide to Celiac Disease HLA Genetics. Am J Gastroenterol. 2019;114(10):1587-1592. doi: 10.14309/ajg.0000000000000310.
  37. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut. 1998 Aug;43(2):187-9.
  38. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol. 2000;18:53-81.
  39. Al-Dauig B A , Al-Agha AE , Alshamrani HM. Int J Med Res Prof .Multiple Autoimmune Diseases: Celiac Disease, Autoimmune Hypothyrodism, Diabetes Mellitus, Addison’s disease in Lady 14 Years Old . Int J Med Res Prof. 2018 Mar; 4(2); 248-50.
  40. Cosnes J, Cellier C, Viola S, Colombel JF, Michaud L, Sarles J. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol. 2008Jul;6(7):753-8. doi: 10.1016/j.cgh.2007.12.022. Epub 2008 Feb 6.
  41. Kumar V,  Rajadhyaksha M, and  Wortsman J. Celiac Disease-Associated Autoimmune Endocrinopathies .Clin Diagn Lab Immunol. 2001; 8(4): 678–685. doi: 10.1128/CDLI.8.4.678-685.2001.
  42. Lauret E, Rodrigo L. Celiac disease and autoimmune-associated conditions. Biomed Res Int. 2013;2013:127589. doi: 10.1155/2013/127589. Epub 2013 Jul 24.
  43. Ventura A,  Magazzù G,  Greco L. Duration Of Exposure To Gluten And Risk For Autoimmune Disorders In Patients With Celiac Disease. 1999. Gastroenterology 117(2):297-303.
  44. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002 Aug;23(4):464-83.
  45. Lundin KE, Wijmenga C. Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol. 2015;12:507–15.
  46. Cataldo F, Marino V. Increased prevalence of autoimmune diseases in firstdegree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr.2003; 36:470–473.
  47. Senti S, Müller J. Addison's disease in the framework of poly-glandular    autoimmune syndromes: 3 case reports. Schweiz Med Wochenschr. 1992 1;122(5):147-52.
  48. Wallaschofski H, Meyer A, Tuschy U, Lohmann T. HLA-DQA10301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res. 2003;35(2):120-4.
  49. Betterle C, Lazzarotto F, Spadaccino AC, BassoD, PlebaniM, Pedini B,  et al. Celiac disease in North Italian patients with autoimmune Addison’s disease. European Journal of Endocrinology .2006; 154 :275–279.
  50. Valentino R, Savastano S, Tommaselli AP, Dorato M, Scarpitta MT, Gigante M, Lombardi G, Troncone R. Unusual association of thyroiditis, Addison's disease, ovarian failure and celiac disease in a young woman. J Endocrinol Invest. 1999;22(5):390-4.
  51. Elfstro¨P, Montgomery SM, Ka¨mpe O, Anders Ekbom A, and Ludvigsson JF. Risk of Primary Adrenal Insufficiency in Patients with celiac disease. The Journal of Clinical Endocrinology & Metabolism  2007;92(9):3595–3598. doi: 10.1210/jc.2007-0960.
  52. O'Leary C, Walsh CH, Wieneke P, O'Regan P, Buckley B, O'Halloran DJ, Ferriss JB, Quigley EM, Annis P, Shanahan F, Cronin CC. Coeliac disease and autoimmune Addison's disease: a clinical pitfall. QJM. 2002;95(2):79-82
  53. Walker MD, Zylberberg HM, Green PHR, Katz MS Endocrine complications of celiac disease: a case report and review of the literature. Endocr Res. 2019;44(1-2):27-45. doi: 10.1080/07435800.2018.1509868. Epub 2018 Sep 10.
  54. Reunala T, Salmi J, Karvonen J. Dermatitis herpetiformis and coeliac disease associated with Addison’s disease. Arch Dermatol .1987; 123:930–2.
  55. Heneghan MA, McHugh P, Stevens FM, McCarthy CF. Addison’s disease and selective IgA deficiency in two coeliac patients. Scand J Gastroenterol 1997; 32:509–11.
  56. Candrina R, Di Stefano O. Exacerbation of celiac disease after cure of Cushings disease. Am J Med 1993 ; 95 341.Google Scholar
  57. Confaloneieri F, Pedretti D, Parisio E. Adult onset celiac disease hidden by chronic steroid therapy for a skin disease. Am J Me1995; 99:439. Google Scholar
  58. Bergrem H, Opedal I. Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein binding. Scand J Gastroenterol 1983; 18:545–9.Google Scholar.
  59. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, et al. HLA types in celiac disease patients not carrying the DQA1*05–DQB1*02 (DQ2) heterodimer:results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469–477.
  60. Rachisan A L,. Pop LE, Parvan A, Samasca G, Bizo A, HruscaA Histopathological correlations and HLA-DQ/ DR typing in coexisting celiac disease and type 1 diabetes in children – case report and literature review  . International Journal of the Bioflux Society. 2017; 9 (1) :11-15.
  61. Szaflarska-Popławska A. Coexistence of coeliac disease and type 1 diabetes Prz Gastroenterol. 2014; 9(1): 11–17. doi: 10.5114/pg.2014.40844.
  62. Megiorni F, Mora B, Bonamico M, Barbato M, Montuori M, et al. HLA-DQ and susceptibility to celiac disease:evidence for gender differences and parent-of-origin effects. Am J Gastroenterol 2008;103:997–1003.
  63. Lewis C, Book L, Black J, Sawitzke A, Cannon-Albright L, Zone J, Neuhausen S. Celiac disease and human leukocyte antigen genotype: accuracy of diagnosis in self-diagnosed individuals, dosage effect, and sibling risk. J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):22-7.
  64. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens. 2003;61(2):105-17.
  65. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, et al. HLA types in celiac disease patients not carrying the DQA1_05-DQB1_02 (DQ2). heterodimer: results from the European genetics cluster on celiac disease. Human Immunol. 2003; 64:469–77. doi: 10.1016/S0198-8859(03)00027-2
  66. van Belzen MJ, Koeleman BP, Crusius JB, Meijer JW, Bardoel AF, Pearson PL, Sandkuijl LA, Houwen RH, Wijmenga C. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun. 2004;5(3):215-20.
  67. Louka AS, Moodie SJ, Karell K, Bolognesi E, Ascher H, Greco L, Momigliano-Richiardi P, Partanen J, Ciclitira PJ, Sollid LM; European Genetics Cluster on Celiac Disease. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum Immunol. 2003;64(3):350-8.
  68. Spurkland A, Sollid LM, Polanco I, et al. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992;35:188–92.
  69. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterol 1993; 105:910–22.
  70. Tuysuz B, Dursun A, Kutlu Tuberculosis, et al. HLA-DQ alleles in patients with celiac disease in Turkey. Tissue Antigens 2001;57(6)540-2.
  71. Badenhoop K, Walfish PG, Rau H, et al. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 1995; 80:2112–17.

Contact SPER Publications

SPER Publications and Solutions Pvt. Ltd.

HD - 236,
Near The Shri Ram Millenium School,
Sector 135,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India